Dual roles of NRF2 in tumor prevention and progression: Possible implications in cancer treatment

Free Radical Biology and Medicine

Volumn 79, Issue , 2015, Pages 292-299

  Moon, Eui Jung ^a   Giaccia, Amato ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Antioxidant response element; ARE; Cancer; CNC family; NRF2; Oxidative stress; Small MAF

Indexed keywords

ANTIOXIDANT; BRUSATOL; LUTEOLIN; TRANSCRIPTION FACTOR NRF2; NFE2L2 PROTEIN, HUMAN;

ANTIOXIDANT ACTIVITY; CANCER INHIBITION; CANCER PREVENTION; CANCER THERAPY; CARCINOGENESIS; CELL STRESS; DEFENSE MECHANISM; HYPOXIA; METABOLISM; MODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; TUMOR GROWTH; ANIMAL; DISEASE COURSE; GENETICS; HUMAN; KNOCKOUT MOUSE; MOUSE; NEOPLASMS; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANIMALS; DISEASE PROGRESSION; GENES, TUMOR SUPPRESSOR; HUMANS; HYPOXIA; MICE; MICE, KNOCKOUT; NEOPLASMS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 84923222319     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2014.11.009     Document Type: Review

References (152)

1. J.D. Hayes, and M. McMahon Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention Cancer Lett. 174 2001 103 113
2. AK. Jaiswal Nrf2 signaling in coordinated activation of antioxidant gene expression Free Radic. Biol. Med. 36 2004 1199 1207
3. H Motohashi, and M. Yamamoto Carcinogenesis and transcriptional regulation through Maf recognition elements Cancer Sci. 98 2007 135 139
4. Kannan MB, Solovieva V, Blank V. The small MAF transcription factors MAFF, MAFG and MAFK: current knowledge and perspectives. Biochim. Biophys. Acta 2012; 1823:1841-1846.
5. K Itoh, T Ishii, N Wakabayashi, and M. Yamamoto Regulatory mechanisms of cellular response to oxidative stress Free Radic. Res. 31 1999 319 324
6. V. Blank Small Maf proteins in mammalian gene control: mere dimerization partners or dynamic transcriptional regulators? J. Mol Biol 376 2008 913 925
7. A Eychene, N Rocques, and C. Pouponnot A new MAFia in cancer Nat. Rev. Cancer 8 2008 683 693
8. DE. Nerland The antioxidant/electrophile response element motif Drug Metab. Rev. 39 2007 235 248
9. J Alam, D Stewart, and C Touchard Nrf2, a cap'n'collar transcription factor, regulates induction of the heme oxygenase-1 gene J. Biol. Chem. 274 1999 26071 26078
10. A Kobayashi, E Ito, and T Toki Molecular cloning and functional characterization of a new cap'n' collar family transcription factor Nrf3 J. Biol. Chem. 274 1999 6443 6452
11. J Jeyapaul, and AK. Jaiswal Nrf2 and c-Jun regulation of antioxidant response element (ARE)-mediated expression and induction of gamma-glutamylcysteine synthetase heavy subunit gene Biochem. Pharmacol. 59 2000 1433 1439
12. L Leung, M Kwong, and S Hou Deficiency of the Nrf1 and Nrf2 transcription factors results in early embryonic lethality and severe oxidative stress J. Biol. Chem. 278 2003 48021 48029
13. Y Zhang, A Kobayashi, M Yamamoto, and JD. Hayes The Nrf3 transcription factor is a membrane-bound glycoprotein targeted to the endoplasmic reticulum through its N-terminal homology box 1 sequence J. Biol. Chem. 284 2009 3195 3210
14. C Yoshida, F Tokumasu, and KI Hohmura Long range interaction of cis-DNA elements mediated by architectural transcription factor Bach1 Genes Cells 4 1999 643 655
15. T Oyake, K Itoh, and H Motohashi Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site Mol. Cell. Biol. 16 1996 6083 6095
16. A Muto, H Hoshino, and L Madisen Identification of Bach2 as a B-cell-specific partner for small maf proteins that negatively regulate the immunoglobulin heavy chain gene 3′ enhancer EMBO J. 17 1998 5734 5743
17. J Sun, H Hoshino, and K Takaku Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene EMBO J. 21 2002 5216 5224
18. S Dhakshinamoorthy, AK Jain, DA Bloom, and AK. Jaiswal Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants J. Biol. Chem. 280 2005 16891 16900
19. T Tahara, J Sun, K Igarashi, and S. Taketani Heme-dependent up-regulation of the alpha-globin gene expression by transcriptional repressor Bach1 in erythroid cells Biochem. Biophys. Res. Commun. 324 2004 77 85
20. K Itoh, N Wakabayashi, and Y Katoh Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain Genes Dev. 13 1999 76 86
21. Y Katoh, K Itoh, and E Yoshida Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription Genes Cells 6 2001 857 868
22. P Nioi, T Nguyen, PJ Sherratt, and CB. Pickett The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation Mol. Cell. Biol. 25 2005 10895 10906
23. M McMahon, N Thomas, and K Itoh Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron J. Biol. Chem. 279 2004 31556 31567
24. H Wang, K Liu, and M Geng RXRalpha inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2 Cancer Res. 73 2013 3097 3108
25. AT Dinkova-Kostova, WD Holtzclaw, and RN Cole Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants Proc. Natl. Acad. Sci. USA 99 2002 11908 11913
26. KR Sekhar, G Rachakonda, and ML. Freeman Cysteine-based regulation of the CUL3 adaptor protein Keap1 Toxicol. Appl. Pharmacol. 244 2010 21 26
27. DD Zhang, and M. Hannink Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress Mol. Cell. Biol. 23 2003 8137 8151
28. K Chan, R Lu, JC Chang, and Kan YW. NRF2 a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development Proc. Natl. Acad. Sci. USA 93 1996 13943 13948
29. N Wakabayashi, K Itoh, and J Wakabayashi Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation Nat. Genet. 35 2003 238 245
30. HY Cho, AE Jedlicka, and SP Reddy Role of NRF2 in protection against hyperoxic lung injury in mice Am. J. Respir. Cell Mol. Biol. 26 2002 175 182
31. NM Reddy, SR Kleeberger, and TW Kensler Disruption of Nrf2 impairs the resolution of hyperoxia-induced acute lung injury and inflammation in mice J. Immunol. 182 2009 7264 7271
32. K Itoh, T Chiba, and S Takahashi An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements Biochem. Biophys. Res. Commun. 236 1997 313 322
33. K Chan, and YW. Kan Nrf2 is essential for protection against acute pulmonary injury in mice Proc. Natl. Acad. Sci. USA 96 1999 12731 12736
34. A Enomoto, K Itoh, and E Nagayoshi High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes Toxicol. Sci. 59 2001 169 177
35. EL Travis, G Rachakonda, and X Zhou NRF2 deficiency reduces life span of mice administered thoracic irradiation Free Radic. Biol. Med. 51 2011 1175 1183
36. M Ramos-Gomez, MK Kwak, and PM Dolan Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice Proc. Natl. Acad. Sci. USA 98 2001 3410 3415
37. K Iida, K Itoh, and Y Kumagai Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis Cancer Res. 64 2004 6424 6431
38. C Xu, MT Huang, and G Shen Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2 Cancer Res. 66 2006 8293 8296
39. TO Khor, MT Huang, and A Prawan Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer Cancer Prev. Res 1 2008 187 191
40. L Becks, M Prince, and H Burson Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene BMC Cancer 10 2010 540
41. H Satoh, T Moriguchi, and K Taguchi Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung Carcinogenesis 31 2010 1833 1843
42. DR Stacy, K Ely, and PP Massion Increased expression of nuclear factor E2 p45-related factor 2 (NRF2) in head and neck squamous cell carcinomas Head Neck 28 2006 813 818
43. CF Huang, L Zhang, and SR Ma Clinical significance of Keap1 and Nrf2 in oral squamous cell carcinoma PloS One 8 2013 e83479
44. Y Kawasaki, H Okumura, and Y Uchikado Nrf2 is useful for predicting the effect of chemoradiation therapy on esophageal squamous cell carcinoma. Ann Surg. Oncol. 2014
45. A Singh, V Misra, and RK Thimmulappa Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer PLoS Med. 3 2006 e420
46. LM Solis, C Behrens, and W Dong Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features Clin. Cancer Res. 16 2010 3743 3753
47. T Shibata, S Saito, and A Kokubu Global downstream pathway analysis reveals a dependence of oncogenic NF-E2-related factor 2 mutation on the mTOR growth signaling pathway Cancer Res. 70 2010 9095 9105
48. H Yang, W Wang, and Y Zhang The role of NF-E2-related factor 2 in predicting chemoresistance and prognosis in advanced non-small-cell lung cancer Clin. Lung Cancer 12 2011 166 171
49. D Inoue, T Suzuki, and Y Mitsuishi Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma Cancer Sci. 103 2012 760 766
50. H Merikallio, P Paakko, and VL Kinnula Nuclear factor erythroid-derived 2-like 2 (Nrf2) and DJ1 are prognostic factors in lung cancer Hum. Pathol. 43 2012 577 584
51. T Shibata, A Kokubu, and M Gotoh Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer Gastroenterology 135 1358-1368 2008 1368 e1351 1354
52. J Wang, M Zhang, and L Zhang Correlation of Nrf2, HO-1, and MRP3 in gallbladder cancer and their relationships to clinicopathologic features and survival J. Surg. Res. 164 2010 e99 105
53. PA Konstantinopoulos, D Spentzos, and E Fountzilas Keap1 mutations and Nrf2 pathway activation in epithelial ovarian cancer Cancer Res. 71 2011 5081 5089
54. JY Park, YW Kim, and YK. Park Nrf2 expression is associated with poor outcome in osteosarcoma Pathology 44 2012 617 621
55. JM Hartikainen, M Tengstrom, and VM Kosma Genetic polymorphisms and protein expression of NRF2 and sulfiredoxin predict survival outcomes in breast cancer Cancer Res. 72 2012 5537 5546
56. Hayden A, Douglas J, Sommerlad M et al. The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer. Urol. Oncol.; 2014.
57. L Ji, Y Wei, T Jiang, and S. Wang Correlation of Nrf2, NQO1, MRP1, cmyc and p53 in colorectal cancer and their relationships to clinicopathologic features and survival Int. J. Clin. Exp. Pathol. 7 2014 1124 1131
58. XF Hu, J Yao, and SG Gao Nrf2 overexpression predicts prognosis and 5-fu resistance in gastric cancer Asian Pacific J. Cancer Prev 14 2013 5231 5235
59. X Ji, H Wang, and J Zhu Correlation of Nrf2 and HIF-1alpha in glioblastoma and their relationships to clinicopathologic features and survival Neurol. Res. 35 2013 1044 1050
60. XJ Ji, SH Chen, and L Zhu Knockdown of NF-E2-related factor 2 inhibits the proliferation and growth of U251MG human glioma cells in a mouse xenograft model Oncol. Rep. 30 2013 157 164
61. Y Soini, M Eskelinen, and P Juvonen Nuclear Nrf2 expression is related to a poor survival in pancreatic adenocarcinoma Pathol. Res. Pract. 210 2014 35 39
62. GM DeNicola, FA Karreth, and TJ Humpton Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis Nature 475 2011 106 109
63. HC Huang, T Nguyen, and CB. Pickett Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription J. Biol. Chem. 277 2002 42769 42774
64. DA Bloom, and AK. Jaiswal Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression J. Biol. Chem. 278 2003 44675 44682
65. SB Cullinan, D Zhang, and M Hannink Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival Mol. Cell. Biol. 23 2003 7198 7209
66. R Yu, W Lei, and S Mandlekar Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals J. Biol. Chem. 274 1999 27545 27552
67. KW Kang, JH Ryu, and SG. Kim The essential role of phosphatidylinositol 3-kinase and of p38 mitogen-activated protein kinase activation in the antioxidant response element-mediated rGSTA2 induction by decreased glutathione in H4IIE hepatoma cells Mol. Pharmacol. 58 2000 1017 1025
68. LM Zipper, and RT. Mulcahy Inhibition of ERK and p38 MAP kinases inhibits binding of Nrf2 and induction of GCS genes Biochem. Biophys. Res. Commun. 278 2000 484 492
69. K Nakaso, H Yano, and Y Fukuhara PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells FEBS Lett. 546 2003 181 184
70. WS Wu, JR Wu, and CT. Hu Signal cross talks for sustained MAPK activation and cell migration: the potential role of reactive oxygen species Cancer Metastasis Rev. 27 2008 303 314
71. S Eser, A Schnieke, G Schneider, and D. Saur Oncogenic KRAS signalling in pancreatic cancer Br. J. Cancer 111 2014 817 822
72. D Hanahan, and RA. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
73. Y Mitsuishi, K Taguchi, and Y Kawatani Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming Cancer Cell 22 2012 66 79
74. Y Hirotsu, F Katsuoka, and R Funayama Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks Nucleic Acids Res. 40 2012 10228 10239
75. D Malhotra, E Portales-Casamar, and A Singh Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis Nucleic Acids Res. 38 2010 5718 5734
76. IP Tomlinson, NA Alam, and AJ Rowan Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer Nat. Genet. 30 2002 406 410
77. J Adam, E Hatipoglu, and L O'Flaherty Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling Cancer Cell 20 2011 524 537
78. S Homma, Y Ishii, and Y Morishima Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer Clin. Cancer Res. 15 2009 3423 3432
79. GS Shim, S Manandhar, and DH Shin Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathway Free Radic. Biol. Med. 47 2009 1619 1631
80. XJ Wang, Z Sun, and NF Villeneuve Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2 Carcinogenesis 29 2008 1235 1243
81. T Jiang, N Chen, and F Zhao High levels of Nrf2 determine chemoresistance in type II endometrial cancer Cancer Res. 70 2010 5486 5496
82. JT McDonald, K Kim, and AJ Norris Ionizing radiation activates the Nrf2 antioxidant response Cancer Res. 70 2010 8886 8895
83. A Singh, M Bodas, and N Wakabayashi Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance Antioxid. Redox Signal. 13 2010 1627 1637
84. T Iida, E Mori, and K Mori Co-expression of gamma-glutamylcysteine synthetase sub-units in response to cisplatin and doxorubicin in human cancer cells Int. J. Cancer 82 1999 405 411
85. S Jayakumar, A Kunwar, and SK Sandur Differential response of DU145 and PC3 prostate cancer cells to ionizing radiation: role of reactive oxygen species, GSH and Nrf2 in radiosensitivity Biochim. Biophys. Acta 1840 2014 485 494
86. AC Wild, HR Moinova, and RT. Mulcahy Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2 J. Biol. Chem. 274 1999 33627 33636
87. R Januchowski, K Wojtowicz, and P Sujka-Kordowska MDR gene expression analysis of six drug-resistant ovarian cancer cell lines BioMed Res. Int 2013 2013 241763
88. S Henness, MW Davey, RM Harvie, and RA. Davey Fractionated irradiation of H69 small-cell lung cancer cells causes stable radiation and drug resistance with increased MRP1, MRP2, and topoisomerase IIalpha expression Int. J. Radiat. Oncol. Biol. Phys. 54 2002 895 902
89. JM Maher, MZ Dieter, and LM Aleksunes Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway Hepatology 46 2007 1597 1610
90. V Vollrath, AM Wielandt, M Iruretagoyena, and J. Chianale Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene Biochem. J. 395 2006 599 609
91. A Hayashi, H Suzuki, and K Itoh Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts Biochem. Biophys. Res. Commun. 310 2003 824 829
92. JM Brown, and AJ. Giaccia The unique physiology of solid tumors: opportunities (and problems) for cancer therapy Cancer Res. 58 1998 1408 1416
93. EB Rankin, and AJ. Giaccia The role of hypoxia-inducible factors in tumorigenesis Cell Death Differ. 15 2008 678 685
94. MW Dewhirst, Y Cao, and B. Moeller Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response Nat. Rev. Cancer 8 2008 425 437
95. 2 tension Proc. Natl. Acad. Sci. USA 92 1995 5510 5514
96. GL Wang, and GL. Semenza Purification and characterization of hypoxia-inducible factor 1 J. Biol. Chem. 270 1995 1230 1237
97. E Laughner, P Taghavi, and K Chiles HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression Mol. Cell. Biol. 21 2001 3995 4004
98. NS Chandel, E Maltepe, and E Goldwasser Mitochondrial reactive oxygen species trigger hypoxia-induced transcription Proc. Natl. Acad. Sci. USA 95 1998 11715 11720
99. P Goyal, N Weissmann, and F Grimminger Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen species Free Radic. Biol. Med. 36 2004 1279 1288
100. E Berra, E Benizri, and A Ginouves HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia EMBO J. 22 2003 4082 4090
101. KD Mansfield, RD Guzy, and Y Pan Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation Cell Metab. 1 2005 393 399
102. RT Kolamunne, IH Dias, and AB Vernallis Nrf2 activation supports cell survival during hypoxia and hypoxia/reoxygenation in cardiomyoblasts; the roles of reactive oxygen and nitrogen species Redox Biol 1 2013 418 426
103. V Malec, OR Gottschald, and S Li HIF-1 alpha signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells Free Radic. Biol. Med. 48 2010 1626 1635
104. P Gong, B Hu, and D Stewart Cobalt induces heme oxygenase-1 expression by a hypoxia-inducible factor-independent mechanism in Chinese hamster ovary cells: regulation by Nrf2 and MafG transcription factors J. Biol. Chem. 276 2001 27018 27025
105. TH Kim, EG Hur, and SJ Kang NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1alpha Cancer Res. 71 2011 2260 2275
106. JT Phillips, and RJ. Fox BG-12 in multiple sclerosis Semin. Neurol. 33 2013 56 65
107. JV Venci, and MA. Gandhi Dimethyl fumarate (Tecfidera): a new oral agent for multiple sclerosis Ann. Pharmacother. 47 2013 1697 1702
108. S Magesh, Y Chen, and L. Hu Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents Med. Res. Rev. 32 2012 687 726
109. C Hu, AL Eggler, AD Mesecar, and RB. van Breemen Modification of keap1 cysteine residues by sulforaphane Chem. Res. Toxicol. 24 2011 515 521
110. Y Zhang, TW Kensler, and CG Cho Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates Proc. Natl. Acad. Sci. USA 91 1994 3147 3150
111. FL Chung, CC Conaway, CV Rao, and BS. Reddy Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate Carcinogenesis 21 2000 2287 2291
112. JW Fahey, X Haristoy, and PM Dolan Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors Proc. Natl. Acad. Sci. USA 99 2002 7610 7615
113. CC Conaway, CX Wang, and B Pittman Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice Cancer Res. 65 2005 8548 8557
114. SV Singh, R Warin, and D Xiao Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells Cancer Res. 69 2009 2117 2125
115. E Bertl, H Bartsch, and C. Gerhauser Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention Mol. Cancer Ther. 5 2006 575 585
116. R Davis, KP Singh, R Kurzrock, and S. Shankar Sulforaphane inhibits angiogenesis through activation of FOXO transcription factors Oncol. Rep. 22 2009 1473 1478
117. M Lenzi, C Fimognari, and P. Hrelia Sulforaphane as a promising molecule for fighting cancer Cancer Treat. Res. 159 2014 207 223
118. Cente SKCC. Study to evaluate the effect of sulforaphane in broccoli sprout extract on breast tissue. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2009 [cited 2014 June 24]. Available from: 〈http://clinicaltrials.gov/ct2/show/NCT00982319〉. NLM identifier: NCT00982319.
119. Institute OKC. Sulforaphane in treating patients with recurrent prostate cancer. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2010 [cited 2014 June 24]. Available from: 〈http://clinicaltrials.gov/ct2/show/NCT01228084〉. NLM identifier: NCT01228084.
120. University H. Pilot study evaluating broccoli sprouts in advanced pancreatic cancer [POUDER Trial]. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2013 [cited 2014 June 24]. Available from: 〈http://clinicaltrials.gov/ct2/show/NCT01879878〉. NLM identifier: NCT01879878.
121. University TAM. Cruciferous vegetable intake and histone status in screening colonoscopy patients. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2011 [cited 2014 June 24]. Available from: 〈http://clinicaltrials.gov/ct2/show/NCT01344330〉. NLM identifier: NCT01879878.
122. JM Patlolla, and CV. Rao Triterpenoids for cancer prevention and treatment: current status and future prospects Curr. Pharm. Biotechnol. 13 2012 147 155
123. A Cleasby, J Yon, and PJ Day Structure of the BTB domain of Keap1 and its interaction with the triterpenoid antagonist CDDO PloS One 9 2014 e98896
124. (de) D Zeeuw, T Akizawa, and R Agarwal Rationale and trial design of bardoxolone methyl evaluation in patients with chronic kidney disease and type 2 diabetes: the occurrence of renal events (BEACON) Am. J. Nephrol. 37 2013 212 222
125. D Ren, NF Villeneuve, and T Jiang Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism Proc. Natl. Acad. Sci. USA 108 2011 1433 1438
126. X Tang, H Wang, and L Fan Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs Free Radic. Biol. Med. 50 2011 1599 1609
127. S Chian, R Thapa, and Z Chi Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo Biochem. Biophys. Res. Commun. 447 2014 602 608
128. XJ Wang, JD Hayes, CJ Henderson, and CR. Wolf Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha Proc. Natl. Acad. Sci. USA 104 2007 19589 19594
129. T Tarumoto, T Nagai, and K Ohmine Ascorbic acid restores sensitivity to imatinib via suppression of Nrf2-dependent gene expression in the imatinib-resistant cell line Exp. Hematol. 32 2004 375 381
130. H Motohashi, JA Shavit, and K Igarashi The world according to Maf Nucleic Acids Res. 25 1997 2953 2959
131. JR Newman, and AE. Keating Comprehensive identification of human bZIP interactions with coiled-coil arrays Science 300 2003 2097 2101
132. R Venugopal, and Jaiswal AK. Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes Oncogene 17 1998 3145 3156
133. V Novotny, EE Prieschl, and R Csonga Nrf1 in a complex with fosB, c-jun, junD and ATF2 forms the AP1 component at the TNF alpha promoter in stimulated mast cells Nucleic Acids Res. 26 1998 5480 5485
134. K Ogita, M Kubo, and N Nishiyama Enhanced binding activity of nuclear antioxidant-response element through possible formation of Nrf2/Fos-B complex after in vivo treatment with kainate in murine hippocampus Neuropharmacology 46 2004 580 589
135. CH He, P Gong, and B Hu Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation J. Biol. Chem. 276 2001 20858 20865
136. M Nishizawa, K Kataoka, and N Goto v-maf, a viral oncogene that encodes a leucine zipper motif Proc. Natl. Acad. Sci. USA 86 1989 7711 7715
137. K Kataoka, KT Fujiwara, M Noda, and Nishizawa M. MafB a new Maf family transcription activator that can associate with Maf and Fos but not with Jun Mol. Cell. Biol. 14 1994 7581 7591
138. M Sakai, J Imaki, and K Yoshida Rat maf related genes: specific expression in chondrocytes, lens and spinal cord Oncogene 14 1997 745 750
139. DR Crawford, KP Leahy, and Y Wang Oxidative stress induces the levels of a MafG homolog in hamster HA-1 cells Free Radic. Biol. Med. 21 1996 521 525
140. JA Moran, EL Dahl, and RT. Mulcahy Differential induction of mafF, mafG and mafK expression by electrophile-response-element activators Biochem. J. 361 2002 371 377
141. T Nguyen, HC Huang, and CB. Pickett Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by MafK J. Biol. Chem. 275 2000 15466 15473
142. MG Marini, K Chan, and L Casula hMAF, a small human transcription factor that heterodimerizes specifically with Nrf1 and Nrf2 J. Biol. Chem. 272 1997 16490 16497
143. H Motohashi, F Katsuoka, and JA Shavit Positive or negative MARE-dependent transcriptional regulation is determined by the abundance of small Maf proteins Cell 103 2000 865 875
144. F Katsuoka, H Motohashi, and T Ishii Genetic evidence that small maf proteins are essential for the activation of antioxidant response element-dependent genes Mol. Cell. Biol. 25 2005 8044 8051
145. JS Choi, LT Zheng, and E Ha Comparative genomic hybridization array analysis and real-time PCR reveals genomic copy number alteration for lung adenocarcinomas Lung 184 2006 355 362
146. F Schembri, S Sridhar, and C Perdomo MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium Proc. Natl. Acad. Sci. USA 106 2009 2319 2324
147. X Ding, Y Yang, and B Han Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation PloS One 9 2014 e95307
148. R Lucito, S Suresh, and K Walter Copy-number variants in patients with a strong family history of pancreatic cancer Cancer Biol. Ther. 6 2007 1592 1599
149. A Martinez-Hernandez, H Gutierrez-Malacatt, and K Carrillo-Sanchez Small MAF genes variants and chronic myeloid leukemia Eur. J. Haematol. 92 2014 35 41
150. I Amit, A Citri, and T Shay A module of negative feedback regulators defines growth factor signaling Nat. Genet. 39 2007 503 512
151. K Ueda, J Xu, and H Morimoto MafG controls the hypoxic response of cells by accumulating HIF-1alpha in the nuclei FEBS Lett. 582 2008 2357 2364
152. N Shimokawa, I Kumaki, and CH Qiu Extracellular acidification enhances DNA binding activity of MafG-FosB heterodimer J. Cell. Physiol. 205 2005 77 85